Practical organisation of preventive cardiology programmes: Integrating prevention and rehabilitation

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 16, Issue SUPPL. 2, 2009, Pages

  Saner, Hugo ^a   Wood, David ^b  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIET THERAPY; DISEASE COURSE; EXERCISE; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEART INFARCTION; HUMAN; LIFESTYLE MODIFICATION; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; PROPHYLAXIS; REHABILITATION CARE; REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 70349292897     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjr.0000359234.65646.7a     Document Type: Review

References (20)

1. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14 (Suppl 2):S1-S113. (Pubitemid 47339826)
2. Taylor R, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116:682-692.
3. Secondary prevention through cardiac rehabilitation. 2008 Update. From knowledge to implementation. A position paper from the cardiac rehabilitation section of the european association for cardiovascular prevention and rehabilitation. Eur J Cardiovasc Prev Rehabil 2009. (In press).
4. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrion, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007; 115:2675-2682.
5. Clark AM, Hartling L, Vandermeer B, McAlister FA, et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005; 143:659-672.
6. Allender S, Scharbotough P, Peto V, Rayner M, Leal J, Luengo-Fernández R, Gray A. European Cardiovascular disease statistics. 2008 edition. London: British Heart Foundation; 2008.
7. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003.
8. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, on behalf of EUROASPIRE study Group. Cardiovascular prevention guidelines-the clinical reality: a comparison of EUROASPIRE I, II and III surveys in 8 European countries. Lancet 2009; 372:929-940.
9. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U, on behalf of EUROASPIRE study Group. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from twenty two European countries. EUROASPIRE Study Group. Europ J Cardiovasc Prev Rehabilitation 2009; 16:121-137.
10. Oldridge N, Furlong W, Feeny D, Torrance G, Guyatt G, Crowe J, Jones N. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 1993; 72:154-161.
11. Kotseva K, Wood D, De Bacquer D, Heidrich J, De Backer G, on behalf of the EUROASPIRE II Study Group. Cardiac rehabilitation for coronary patients: lifestyle, risk factor and therapeutic management. Results from the EUROASPIRE II survey. Eur Heart J 2004; 6 (Suppl J):J17-J26.
12. Needs and priorities in cardiac rehabilitation and secondary prevention in patients with coronary heart disease. WHO Technical Report Series 831. Geneva: World Health Organisation; 1993.
13. Giannuzzi P, Saner H, Björnstad H, Fioretti P, Mendes M, Cohen-Solal A, et al., Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Secondary prevention through cardiac rehabilitation: position paper of the Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Eur Heart J 2003; 24:1273-1278. (Pubitemid 36834643)
14. Giannuzzi P, Temporelli PL, Marchioli R, Maggioni AP, Balestroni G, Ceci V, et al., GOSPEL study. Global secondary prevention strategies to limit event recurrence after myocardial infarction. Results of the GOSPEL Study, a multicenter, randomized controlled trial from the Italian cardiac rehabilitation network. Arch Intern Med 2008, 168, 2194-2204.
15. Wood DA, Kotseva K, Connolly S, Faergeman O, Jennings C, Mead A, et al., on behalf of the EUROACTION Study Group. EUROACTION: a European Society of Cardiology demonstration project in preventive cardiology. A paired cluster randomised controlled trial of a multi-disciplinary family based preventive cardiology programme for coronary patients and asymptomatic high risk individuals. Lancet 2008; 371:1999-2012.
16. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:343-350.
17. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403.
18. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological intervention to improve glycemic control in patients with type 2 diabetes. Lancet 2004; 363:1589-1597.
19. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al., Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modifications or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005; 142:323-332.
20. Gardner AW, Poehlman ET: excercise rehablitation programs for the treatment of claudicatio pain. A meta-analysis. JAMA 1995; 274:975-980.